Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.400
+0.018 (4.68%)
At close: Dec 20, 2024, 4:00 PM
0.399
-0.001 (-0.15%)
After-hours: Dec 20, 2024, 5:59 PM EST
Spruce Biosciences Employees
Spruce Biosciences had 29 employees as of December 31, 2023. The number of employees increased by 2 or 7.41% compared to the previous year.
Employees
29
Change (1Y)
2
Growth (1Y)
7.41%
Revenue / Employee
$244,862
Profits / Employee
-$1,359,552
Market Cap
16.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 29 | 2 | 7.41% |
| Dec 31, 2022 | 27 | 12 | 80.00% |
| Dec 31, 2021 | 15 | -2 | -11.76% |
| Dec 31, 2020 | 17 | 2 | 13.33% |
| Dec 31, 2019 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProPhase Labs | 113 |
| Nephros | 31 |
| MEI Pharma | 28 |
| Unity Biotechnology | 19 |
| Traws Pharma | 18 |
| Innovative Eyewear | 11 |
| Minerva Neurosciences | 9 |
| Synlogic | 6 |
SPRB News
- 10 days ago - Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Benzinga
- 11 days ago - Spruce Biosciences to wind down investment for genetic disorder drug - Reuters
- 11 days ago - Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - Business Wire
- 5 weeks ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 6 weeks ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire
- 6 weeks ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Spruce Biosciences Inc For Securities Law Violations - Accesswire
- 7 weeks ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part - Accesswire
- 7 weeks ago - Investors With Losses Are Invited To Join The Schall Law Firm's Inquiry Into Spruce Biosciences Inc For Possible Securities Law Violations - Accesswire